Clay Siegall is quite active online and with social media. He has his own WordPress blog that addresses multiple issues and observations by the Seattle Genetics CEO. For example, his latest post addressed just how confusing selecting the right type of seafood can be for consumers. The way in which the seafood is caught, as well as the location that the food was caught at. It is becoming more common for individuals to be conscious of where their seafood comes from as well as the methods that were used to obtain the catch.
Another of his blog posts addresses the issues of microbes in the International Space Station. A microbiologist was sent via a Russian rocket to study all of the different types of microbes that were present in the sealed environment. She was especially interested in the growth of staph and how it reacted to the weightless environment. This is just a few of the interesting and informative articles that Clay Siegall supplies to his readers to further their understanding and knowledge of the world and their environment which is something that he understands in depth. He is a brilliant scientist that works tirelessly to bring effective cancer treatment to those people that have not responded well to other forms of cancer treatments.
Clay Siegall founded Seattle Genetics in 1998 and currently serves in several capacities with the company. He is Chairman of the Board, President, as well as his CEO position. He has always had a desire to help people and when the opportunity presented itself after serving with some of the most prolific caner treatment facilities, he jumped at the chance. His company is currently producing a drug called ADCETRIS that is helping many patients that were not having success with other methods of treatment. There are also several other drugs that are in the final testing phases before they will be released to the general public.
Dr. Clay Siegall previously worked with major companies such as Bristol-Meyers Squibb Pharmaceutical Research Institute, the National Cancer Institute, National Institutes of Health, and other well-known companies that have some part in cancer research and development. He attended the University of Maryland where he attained a degree in Biology. He then received his Ph.D. from George Washington University.